Trends in Controlled Substance Prescribing among Adolescents and Young Adults, 2008-2019

Saturday, April 23, 2022

9:15 AM – 9:30 AM US MT

Location: Convention Center: Mile High Ballroom 1EF

CE: Enduring CME: 0.25

Publication Number: 1000.6

Michael S. Toce, Boston Children's Hospital, Boston, MA, United States; kenneth michelson, Boston Children's Hospital, Boston, MA, United States; joel Hudgins, Boston Children's Hospital, Boston, MA, United States; Florence Bourgeois, Boston Children's Hospital, Boston, MA, United States

Presenting Author(s)

Michael S. Toce, MD MS
Instructor of Pediatrics
Boston Children's Hospital
Boston, Massachusetts, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Michael S. Toce, MD MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kenneth Michelson, MD MPH: ● Moderna (Ended In the Past 24 Months) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Pfizer (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Joel D. Hudgins, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Florence Bourgeois, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.